Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for DXCM

Stock Name	DexCom Inc
Ticker	DXCM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2521311074
LEI	549300YSK3QDSFR5EU59

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44
Friday's ETF with Unusual Volume: QQH: The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32
Nasdaq 100 Movers: DXCM, FTNT: In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42
DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages: Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside: When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22
DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform: Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts: DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01
Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM): DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55
DexCom (DXCM) Q2 Revenue Jumps 15%: Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01
Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates: Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16
Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58
HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM): HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13
AVLV's Underlying Holdings Imply 10% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07
DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50
Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock: DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53
Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM): Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58
DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.: Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54
Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM): Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51
Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM): Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57
Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM): Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45
First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM): First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares US Medical Devices UCITS ETF DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-12-03 (Wednesday)	54,521	USD 3,535,687	USD 3,535,687	USD 21,809	USD 64.85	USD 64.45
2025-12-02 (Tuesday)	54,521	USD 3,513,878	USD 3,513,878	USD 50,704	USD 64.45	USD 63.52
2025-12-01 (Monday)	54,521	USD 3,463,174	USD 3,463,174	USD 2,726	USD 63.52	USD 63.47
2025-11-28 (Friday)	54,521	USD 3,460,448	USD 3,460,448	USD 51,250	USD 63.47	USD 62.53
2025-11-27 (Thursday)	54,521	USD 3,409,198	USD 3,409,198	USD 0	USD 62.53	USD 62.53
2025-11-26 (Wednesday)	54,521	USD 3,409,198	USD 3,409,198	USD 45,798	USD 62.53	USD 61.69
2025-11-25 (Tuesday)	54,521	USD 3,363,400	USD 3,363,400	USD -28,351	USD 61.69	USD 62.21
2025-11-24 (Monday)	54,521	USD 3,391,751	USD 3,391,751	USD 107,951	USD 62.21	USD 60.23
2025-11-21 (Friday)	54,521	USD 3,283,800	USD 3,283,800	USD 98,683	USD 60.23	USD 58.42
2025-11-20 (Thursday)	54,521	USD 3,185,117	USD 3,185,117	USD -71,422	USD 58.42	USD 59.73
2025-11-19 (Wednesday)	54,521	USD 3,256,539	USD 3,256,539	USD -23,990	USD 59.73	USD 60.17
2025-11-18 (Tuesday)	54,521	USD 3,280,529	USD 3,280,529	USD 91,596	USD 60.17	USD 58.49
2025-11-17 (Monday)	54,521	USD 3,188,933	USD 3,188,933	USD 23,444	USD 58.49	USD 58.06

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DXCM by Blackrock for IE00BMX0DF60

Show aggregate share trades of DXCM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -848 60.000 56.890 57.201 USD -48,506 77.50 Profit of 17,212 on sale
2025-11-04 BUY 424 62.390 58.880 59.231 USD 25,114 77.67
2025-10-30 SELL -1,272 69.170 68.000 68.117 USD -86,645 77.90 Profit of 12,447 on sale
2025-10-23 SELL -423 71.060 71.500 71.456 USD -30,226 78.11 Profit of 2,815 on sale
2025-10-22 BUY 848 70.700 71.990 71.861 USD 60,938 78.15
2025-10-20 BUY 424 68.430 68.470 68.466 USD 29,030 78.24
2025-10-16 BUY 424 66.330 66.680 66.645 USD 28,257 78.37
2025-09-25 BUY 3,384 68.300 68.570 68.543 USD 231,950 79.10
2025-08-22 SELL -1,692 82.260 82.360 82.350 USD -139,336 79.33 Loss of -5,115 on sale
2025-06-27 SELL -846 86.330 87.480 87.365 USD -73,911 78.63 Loss of -7,386 on sale
2025-06-12 BUY 1,263 82.850 83.610 83.534 USD 105,503 78.32
2025-06-10 SELL -6,736 84.820 86.450 86.287 USD -581,229 78.24 Loss of -54,228 on sale
2025-06-09 SELL -7,999 85.680 86.940 86.814 USD -694,425 78.18 Loss of -69,073 on sale
2025-05-30 SELL -842 85.800 86.800 86.700 USD -73,001 77.80 Loss of -7,497 on sale
2025-05-19 BUY 421 86.960 86.990 86.987 USD 36,622 77.18
2025-05-09 SELL -2,110 84.670 85.710 85.606 USD -180,629 76.73 Loss of -18,721 on sale
2025-04-23 SELL -422 66.860 70.210 69.875 USD -29,487 76.89 Profit of 2,961 on sale
2025-04-17 SELL -422 68.570 68.780 68.759 USD -29,016 77.31 Profit of 3,607 on sale
2025-04-10 BUY 3,376 67.300 73.500 72.880 USD 246,043 77.85
2025-04-04 SELL -844 59.830 61.050 60.928 USD -51,423 78.61 Profit of 14,921 on sale
2025-04-02 SELL -844 68.140 68.520 68.482 USD -57,799 78.73 Profit of 8,653 on sale
2025-03-31 SELL -1,266 68.290 68.750 68.704 USD -86,979 79.01 Profit of 13,044 on sale
2025-03-19 SELL -421 73.380 74.420 74.316 USD -31,287 79.72 Profit of 2,277 on sale
2025-02-28 SELL -842 88.370 88.600 88.577 USD -74,582 80.51 Loss of -6,793 on sale
2025-02-21 BUY 216 88.780 89.870 89.761 USD 19,388 79.73
2025-02-18 BUY 215 90.530 93.250 92.978 USD 19,990 79.14
2025-02-05 BUY 1,257 88.780 88.860 88.852 USD 111,687 77.43
2025-02-04 BUY 1,676 87.460 87.950 87.901 USD 147,322 77.19
2025-01-29 SELL -419 86.430 88.310 88.122 USD -36,923 76.16 Loss of -5,012 on sale
2025-01-23 SELL -419 87.700 87.860 87.844 USD -36,807 74.76 Loss of -5,483 on sale
2025-01-02 SELL -2,713 78.500 79.970 79.823 USD -216,560 74.64 Loss of -14,048 on sale
2024-12-04 BUY 1,290 81.010 82.260 82.135 USD 105,954 73.85
2024-12-03 SELL -430 80.910 81.110 81.090 USD -34,869 73.59 Loss of -3,225 on sale
2024-12-02 SELL -5,148 79.310 80.180 80.093 USD -412,319 73.37 Loss of -34,616 on sale
2024-11-29 SELL -8,580 77.990 79.370 79.232 USD -679,811 73.18 Loss of -51,892 on sale
2024-11-27 SELL -1,287 78.100 78.620 78.568 USD -101,117 72.76 Loss of -7,479 on sale
2024-11-19 BUY 439 74.880 76.610 76.437 USD 33,556 71.78
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-848	60.000	56.890	57.201	USD -48,506	77.50 Profit of 17,212 on sale
2025-11-04	BUY	424	62.390	58.880	59.231	USD 25,114	77.67
2025-10-30	SELL	-1,272	69.170	68.000	68.117	USD -86,645	77.90 Profit of 12,447 on sale
2025-10-23	SELL	-423	71.060	71.500	71.456	USD -30,226	78.11 Profit of 2,815 on sale
2025-10-22	BUY	848	70.700	71.990	71.861	USD 60,938	78.15
2025-10-20	BUY	424	68.430	68.470	68.466	USD 29,030	78.24
2025-10-16	BUY	424	66.330	66.680	66.645	USD 28,257	78.37
2025-09-25	BUY	3,384	68.300	68.570	68.543	USD 231,950	79.10
2025-08-22	SELL	-1,692	82.260	82.360	82.350	USD -139,336	79.33 Loss of -5,115 on sale
2025-06-27	SELL	-846	86.330	87.480	87.365	USD -73,911	78.63 Loss of -7,386 on sale
2025-06-12	BUY	1,263	82.850	83.610	83.534	USD 105,503	78.32
2025-06-10	SELL	-6,736	84.820	86.450	86.287	USD -581,229	78.24 Loss of -54,228 on sale
2025-06-09	SELL	-7,999	85.680	86.940	86.814	USD -694,425	78.18 Loss of -69,073 on sale
2025-05-30	SELL	-842	85.800	86.800	86.700	USD -73,001	77.80 Loss of -7,497 on sale
2025-05-19	BUY	421	86.960	86.990	86.987	USD 36,622	77.18
2025-05-09	SELL	-2,110	84.670	85.710	85.606	USD -180,629	76.73 Loss of -18,721 on sale
2025-04-23	SELL	-422	66.860	70.210	69.875	USD -29,487	76.89 Profit of 2,961 on sale
2025-04-17	SELL	-422	68.570	68.780	68.759	USD -29,016	77.31 Profit of 3,607 on sale
2025-04-10	BUY	3,376	67.300	73.500	72.880	USD 246,043	77.85
2025-04-04	SELL	-844	59.830	61.050	60.928	USD -51,423	78.61 Profit of 14,921 on sale
2025-04-02	SELL	-844	68.140	68.520	68.482	USD -57,799	78.73 Profit of 8,653 on sale
2025-03-31	SELL	-1,266	68.290	68.750	68.704	USD -86,979	79.01 Profit of 13,044 on sale
2025-03-19	SELL	-421	73.380	74.420	74.316	USD -31,287	79.72 Profit of 2,277 on sale
2025-02-28	SELL	-842	88.370	88.600	88.577	USD -74,582	80.51 Loss of -6,793 on sale
2025-02-21	BUY	216	88.780	89.870	89.761	USD 19,388	79.73
2025-02-18	BUY	215	90.530	93.250	92.978	USD 19,990	79.14
2025-02-05	BUY	1,257	88.780	88.860	88.852	USD 111,687	77.43
2025-02-04	BUY	1,676	87.460	87.950	87.901	USD 147,322	77.19
2025-01-29	SELL	-419	86.430	88.310	88.122	USD -36,923	76.16 Loss of -5,012 on sale
2025-01-23	SELL	-419	87.700	87.860	87.844	USD -36,807	74.76 Loss of -5,483 on sale
2025-01-02	SELL	-2,713	78.500	79.970	79.823	USD -216,560	74.64 Loss of -14,048 on sale
2024-12-04	BUY	1,290	81.010	82.260	82.135	USD 105,954	73.85
2024-12-03	SELL	-430	80.910	81.110	81.090	USD -34,869	73.59 Loss of -3,225 on sale
2024-12-02	SELL	-5,148	79.310	80.180	80.093	USD -412,319	73.37 Loss of -34,616 on sale
2024-11-29	SELL	-8,580	77.990	79.370	79.232	USD -679,811	73.18 Loss of -51,892 on sale
2024-11-27	SELL	-1,287	78.100	78.620	78.568	USD -101,117	72.76 Loss of -7,479 on sale
2024-11-19	BUY	439	74.880	76.610	76.437	USD 33,556	71.78

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	2,244,349	123,900	7,301,108	30.7%
2025-09-18	2,096,398	2,923	4,473,314	46.9%
2025-09-17	1,005,017	909	2,841,630	35.4%
2025-09-16	832,635	1,252	1,662,428	50.1%
2025-09-15	415,979	19,554	1,507,100	27.6%
2025-09-12	479,180	25	1,013,014	47.3%
2025-09-11	1,239,171	19	3,292,844	37.6%
2025-09-10	778,899	1	2,102,775	37.0%
2025-09-09	398,555	48,137	1,042,556	38.2%
2025-09-08	597,379	10,948	1,743,480	34.3%
2025-09-05	490,229	0	992,181	49.4%
2025-09-04	833,267	24	1,699,659	49.0%
2025-09-03	1,673,104	582	3,096,450	54.0%
2025-09-02	559,125	6,032	1,379,296	40.5%
2025-08-29	395,483	819	767,429	51.5%
2025-08-28	480,565	39	1,612,270	29.8%
2025-08-27	422,875	756	1,106,762	38.2%
2025-08-26	451,911	15,387	1,316,342	34.3%
2025-08-25	801,886	5,802	2,158,071	37.2%
2025-08-22	279,355	5	826,312	33.8%
2025-08-21	331,378	4,639	798,573	41.5%
2025-08-20	491,337	399	1,003,276	49.0%
2025-08-19	311,145	1,383	842,816	36.9%
2025-08-18	509,896	0	1,182,266	43.1%
2025-08-15	351,714	12,102	630,748	55.8%
2025-08-14	394,332	438	858,593	45.9%
2025-08-13	530,063	302	1,270,620	41.7%
2025-08-12	533,812	115	1,296,848	41.2%
2025-08-11	673,352	144	1,432,682	47.0%
2025-08-08	812,111	647	1,314,352	61.8%
2025-08-07	679,883	11	1,091,906	62.3%
2025-08-06	902,331	283	2,029,615	44.5%
2025-08-05	598,249	68	2,057,698	29.1%
2025-08-04	942,525	17	3,002,291	31.4%
2025-08-01	1,104,059	1,225	2,117,218	52.1%
2025-07-31	1,973,583	3,744	3,201,771	61.6%
2025-07-30	484,427	82	1,520,136	31.9%
2025-07-29	414,317	112	885,534	46.8%
2025-07-28	545,711	900	1,158,616	47.1%
2025-07-25	439,501	851	1,018,375	43.2%
2025-07-24	314,578	49	750,090	41.9%
2025-07-23	342,609	311	689,820	49.7%
2025-07-22	354,194	17,613	750,057	47.2%
2025-07-21	308,164	9,508	783,241	39.3%
2025-07-18	312,697	18,442	836,608	37.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam